Indonesian-made GeNose COVID-19 Test Kits Sell For IDR 62 Million Per Unit

GeNose (BETWEEN)

JAKARTA - Chairman of the Consortium for Research and Innovation for COVID-19 Research and Technology / BRIN Ali Ghufron Mukti said that the rapid screening tool for COVID-19 through exhalation, the products made by the nation's children GeNose will be sold at around Rp. 62 million.

"How much is the selling price for this tool? This is Rp.62 million for the tool," he said, in a webinar, Friday, January 15.

Meanwhile, Head of Production for the GeNose C19 Consortium Eko Fajar Prasetyo said that the COVID-19 test kit will be released in February. GeNose was released together with a distribution permit from the Ministry of Health.

"For the February target, we are now calculating. Our February target is 3,000 releases, God willing," said Eko.

Meanwhile, Minister of Research and Technology / National Research and Innovation Agency Bambang Brodjonegoro revealed that the innovative COVID-19 test kits from the nation's children were flooded with orders.

According to Bambang, orders that have been received have even exceeded production capacity. Therefore, he asked the industries involved in GeNose production to increase production capacity.

"From the industrial side, please make sure that besides we can fulfill orders that have come, which I know is far from the current production capacity. However, we hope that the production capacity can catch up soon," said Bambang.

GeNose is a nationwide rapid screening tool whose test is different from the antigen or swab test. Exhale-based GeNose tests.

Later, the patient's breath sample will be taken using GeNose, if the result is positive, it must still be validated using the standard PCR test swab test.